DNA FY 2020 Earnings — Ginkgo Bioworks Holdings, Inc. Revenue & Financial Results | Market Cap Arena

DNAGinkgo Bioworks Holdings, Inc.

$418M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$77M+41.5% YoY

Gross Profit

$61M79.6% margin

Operating Income

-$137M-178.8% margin

Net Income

-$127M-165.2% margin

EPS (Diluted)

$-4.00

Cash Flow

Operating Cash Flow

-$136M

Free Cash Flow

-$194M

Stock-Based Comp.

$476,000

Balance Sheet

Total Assets

$675M

Total Liabilities

$205M

Stockholders' Equity

$461M

Cash & Equivalents

$381M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$77M	$54M	+41.5%
Gross Profit	$61M	$54M	+12.7%
Operating Income	-$137M	-$72M	-91.4%
Net Income	-$127M	-$119M	-6.1%